Camillotek India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.07 M
- Company Age 38 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.85 M
- Revenue Growth -39.01%
- Profit Growth -61.52%
- Ebitda -59.06%
- Net Worth 8.06%
- Total Assets -16.52%
About Camillotek India
Camillotek India Private Limited (CIPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 January 1987 and has a history of 38 years. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.07 M.
The company currently has active open charges totaling ₹0.85 M.
Nanda Saha and Sujata Roy serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U93090TN1987PTC013953
-
Company No.
013953
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jan 1987
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Camillotek India Private Limited offer?
Camillotek India Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Ayurvedic & Herbal Health Supplement, Herbal Juice, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Pharmaceutical Capsules, Ayurvedic & Herbal Extracts, Plant Extracts, Dietary Supplements.
Who are the key members and board of directors at Camillotek India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nanda Saha
|
Director | 04-Dec-2002 | Current |
| Sujata Roy | Additional Director | 04-Oct-2024 | Current |
Financial Performance of Camillotek India.
Camillotek India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 39.01% decrease. The company also saw a substantial fall in profitability, with a 61.52% decrease in profit. The company's net worth moved up by a moderate rise of 8.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Camillotek India?
Unlock access to Camillotek India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.85 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.05 Cr
- Punjab And Sind Bank : 0.02 Cr
- Punjab & Sind Bank : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jan 1995 | Punjab And Sind Bank | ₹0.20 M | Open |
| 21 Jan 1995 | Punjab & Sind Bank | ₹0.20 M | Open |
| 01 Aug 1987 | Indian Bank | ₹0.45 M | Open |
How Many Employees Work at Camillotek India?
Unlock and access historical data on people associated with Camillotek India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Camillotek India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Camillotek India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
